Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pattern-recognition receptors (PRRs) sensing ALVAC vector components are a specialized group of innate immune sensors that detect the canarypox virus-based ALVAC vector. ALVAC is a highly attenuated, non-replicating poxvirus used as a delivery vehicle in various vaccine candidates, most notably in the RV144 HIV-1 vaccine trial (Rerks-Ngarm et al., 2009). Upon entry into host cells, ALVAC releases viral DNA and generates double-stranded RNA (dsRNA) intermediates, which are detected by cytoplasmic sensors such as cyclic GMP-AMP synthase (cGAS), Absent in Melanoma 2 (AIM2), and the NLRP3 inflammasome (Poli et al., 2013; Poli et al., 2017). The activation of these PRRs triggers downstream signaling pathways, specifically the cGAS-STING axis and inflammasome assembly, leading to the production of Type I interferons (IFN-α/β) and pro-inflammatory cytokines like IL-1β and IL-18. These sensing mechanisms are critical for the immunogenicity of ALVAC-based vaccines, as they provide the necessary danger signals or adjuvant effects required to prime adaptive immune responses. By stimulating these receptors, ALVAC promotes the maturation of dendritic cells and the subsequent activation of T-cells and B-cells. While primarily studied in the context of HIV prevention, ALVAC-sensing PRRs are also relevant in cancer immunotherapy, where the vector is used to deliver tumor-associated antigens. Understanding the specific PRRs involved allows for the rational design of more effective viral vectors and adjuvants that can precisely modulate the innate immune environment to achieve protective immunity.
Agonism of innate immune sensors (cGAS, AIM2, TLR3, NLRP3) to induce pro-inflammatory cytokines and Type I interferons, enhancing adaptive immune responses.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pattern-recognition receptors sensing ALVAC vector components (PRRs (ALVAC)).